Stock AIM AIM IMMUNOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. AIM ImmunoTech Inc.

Equities

AIM

US00901B1052

Market Closed - Nyse
Other stock markets
 04:10:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
0.4282 USD +5.34% Intraday chart for AIM ImmunoTech Inc. -7.91% -2.66%
Apr. 10 AIM Immunotech Announces Positive Top-Line, Protocol-Planned Interim Report Data from the Study of Ampligen Combined with Pembrolizumab for the Treatment of Recurrent Ovarian Cancer CI
Apr. 02 Transcript : AIM ImmunoTech Inc., Q4 2023 Earnings Call, Apr 02, 2024

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Maxim Group Adjusts AIM ImmunoTech Price Target to $3 From $5, Maintains Buy Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AIM Stock
  4. News AIM ImmunoTech Inc.
  5. Analyst Reco.